Findings seen in patients following myocardial infarction. (HealthDay News) — Beta-blocker treatment can lead to a modest increase in depressive symptoms among patients who have myocardial infarction ...

Researchers at the University of Virginia School of Medicine say this finding could open the door to better ways to manage ...

Findings seen for individuals undergoing revascularization after non-ST-segment elevation myocardial infarction ...

Objectives Elevations of cardiac troponin T (cTnT) levels are common after strenuous exercise. We assessed whether the ...

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

Akebia Therapeutics®, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the American Journal of Kidney Disease has ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...